Michael Frumovitz Selected Research

Pyelonephritis

6/2013

Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Frumovitz Research Topics

Disease

60	Neoplasms (Cancer) 02/2024 - 10/2004
55	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 10/2005
22	Endometrial Neoplasms (Endometrial Cancer) 12/2021 - 10/2004
17	Carcinoma (Carcinomatosis) 12/2023 - 06/2005
10	Adenocarcinoma 01/2020 - 10/2004
9	Neoplasm Metastasis (Metastasis) 02/2015 - 08/2006
7	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 08/2011
5	Uterine Neoplasms (Uterine Cancer) 10/2018 - 09/2004
4	Neuroendocrine Carcinoma 01/2024 - 01/2019
4	Lymphatic Metastasis 12/2014 - 04/2008
3	Disease Progression 01/2023 - 02/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2018
3	Adenosquamous Carcinoma 01/2020 - 12/2007
3	Vulvar Neoplasms (Vulvar Cancer) 05/2019 - 01/2004
3	Lymphadenopathy 01/2018 - 12/2010
3	Intraoperative Complications 09/2015 - 10/2008
2	Granulosa Cell Tumor 01/2024 - 01/2023
2	Ovarian Epithelial Carcinoma 10/2022 - 06/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 12/2009
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2019 - 08/2010
2	Pathologic Constriction (Stenosis) 01/2016 - 06/2013
2	Hyperplasia 12/2014 - 10/2004
2	Overweight 05/2012 - 10/2008
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 07/2022
1	Vomiting 01/2021
1	Nausea 01/2021
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2021
1	Small Cell Carcinoma 05/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Pheochromocytoma 01/2020
1	Paraganglioma (Paragangliomas) 01/2020
1	Extranodal Extension 02/2016
1	Lymphedema (Milroy Disease) 02/2016
1	Vascular System Injuries 09/2015
1	Chronic Disease (Chronic Diseases) 07/2015
1	Anaphylaxis (Anaphylactic Shock) 07/2015
1	Leiomyosarcoma 02/2015
1	Endometrial Hyperplasia 02/2015

Drug/Important Bio-Agent (IBA)

6	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2024 - 02/2016
5	PlatinumIBA 01/2023 - 06/2010
5	Coloring Agents (Dyes)IBA 01/2019 - 01/2004
2	NivolumabIBA 01/2023 - 01/2020
2	Hormones (Hormone)IBA 01/2023 - 10/2004
2	Bevacizumab (Avastin)FDA Link 01/2023 - 12/2019
2	Capecitabine (Xeloda)FDA Link 10/2022 - 06/2005
2	taxaneIBA 10/2022 - 06/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022 - 12/2013
2	AntiemeticsIBA 01/2021 - 04/2013
2	pembrolizumabIBA 01/2020 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 10/2018 - 01/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Leuprolide (Lupron)FDA LinkGeneric 01/2023
1	niraparibIBA 01/2023
1	durvalumabIBA 01/2023
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2023
1	MEDI0457IBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	olaparibIBA 12/2021
1	capivasertibIBA 12/2021
1	Ondansetron (Zofran)FDA LinkGeneric 01/2021
1	Granisetron (Kytril)FDA LinkGeneric 01/2021
1	copanlisibIBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	talazoparibIBA 05/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2018
1	Metalloproteases (Metalloproteinases)IBA 01/2018
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2015
1	amsonic acid (DAS)IBA 07/2015

Therapy/Procedure

46	Hysterectomy 12/2023 - 10/2005
40	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 10/2005
32	Therapeutics 01/2024 - 10/2004
17	Drug Therapy (Chemotherapy) 01/2023 - 10/2004
16	Trachelectomy 02/2024 - 09/2008
13	Radiotherapy 12/2023 - 10/2004
9	Laparotomy 09/2015 - 07/2005
7	Length of Stay 07/2022 - 07/2007
6	Minimally Invasive Surgical Procedures 01/2021 - 04/2013
6	Pelvic Exenteration 09/2018 - 12/2009
4	Conservative Treatment 01/2021 - 10/2004
4	Operative Time 01/2020 - 07/2007
3	Surgical Instruments (Clip) 02/2024 - 05/2007
3	Salpingo-oophorectomy 10/2022 - 09/2004
2	Contraindications 01/2024 - 10/2008
2	Cytoreduction Surgical Procedures 01/2024 - 01/2023
2	Hyperthermic Intraperitoneal Chemotherapy 01/2023 - 10/2022
2	Catheters 07/2022 - 01/2016
2	Immunotherapy 01/2022 - 01/2020
2	Adjuvant Radiotherapy 01/2021 - 09/2008
2	Gynecologic Surgical Procedures (Gynecologic Surgery) 11/2013 - 05/2012
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2024
1	Urinary Catheters 07/2022
1	Adjuvant Chemotherapy 12/2019
1	Lasers (Laser) 11/2016
1	Salpingectomy 09/2015
1	Morcellation 02/2015